These outcomes, along with a former report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assist the notion of focusing on ACKR3 as a singular method to modulate the opioid program, which could open new therapeutic avenues for opioid-linked disorders.Disclaimer: The above mentioned is usually a sponsore